TRANSFORMATION OF HUMAN BREAST EPITHELIAL-CELLS BY 7, 12, DIMETHYLBENZ(A)ANTHRACENE, BUT NOT BY N-METHYL-N-NITROSOUREA, IS ACCOMPANIED BY UP-REGULATION OF BASIC FIBROBLAST GROWTH-FACTOR

Citation
G. Lazzaro et al., TRANSFORMATION OF HUMAN BREAST EPITHELIAL-CELLS BY 7, 12, DIMETHYLBENZ(A)ANTHRACENE, BUT NOT BY N-METHYL-N-NITROSOUREA, IS ACCOMPANIED BY UP-REGULATION OF BASIC FIBROBLAST GROWTH-FACTOR, Oncology Reports, 4(6), 1997, pp. 1175-1180
Citations number
28
Categorie Soggetti
Oncology
Journal title
ISSN journal
1021335X
Volume
4
Issue
6
Year of publication
1997
Pages
1175 - 1180
Database
ISI
SICI code
1021-335X(1997)4:6<1175:TOHBEB>2.0.ZU;2-C
Abstract
Normal human breast epithelial cells (HBL100) are immortalized by endo genous SV40 genome and are not tumorigenic in nude mice if injected in the first 50 passages in culture. This cell line also depends on the expression of basic fibroblast growth factor (bFGF) for its viability in culture. The present study was designed to transform these cells wi th chemical carcinogens to establish malignant HBL100 cell lines in or der to evaluate the eventual modulation in the expression of bFGF. In the first experiment, HBL100 cells were treated with 2 mu g/ml of 7, 1 2, dimethylbenz(a)anthracene (DMBA) for two 24 h periods. In a second experiment, HBL100 cells were transformed by exposing them to 20 mu g/ ml of N-methyl-N-nitrosourea (MNU) twice a day for two days. Unlike th e HBL100 parental cell line, the two newly derived cell lines (named r espectively HBLTDMBA and HBLTMNU) were tumorigenic when injected in nu de mice. The expression of bFGF, as measured by immunocytochemistry an d Western blot analysis, was higher in the DMBA-transformed cell line than in the parental HBL100 and MNU-transformed lines. These results d ifferentiate between transformation selectivity by two different carci nogens. The direct-acting carcinogen MNU, which induces point mutation , does not require enhanced expression of bFGF, whereas bFGF may be ne cessary for early events leading towards transformation by carcinogens requiring metabolism for their action, such as DMBA.